Affiliation:
1. Laboratory of Bacteriology and Medical Mycology, Istituto Superiore di Sanità
2. STA, Department of Biology, University of “Tor Vergata,” Rome, Italy
Abstract
ABSTRACT
The activity of moxifloxacin was enhanced by the addition of ethionamide but not by that of cycloserine, thiacetazone, capreomycin,
para
-aminosalicylic acid, or linezolid in BALB/c mice infected with a strain of
Mycobacterium tuberculosis
resistant to isoniazid, rifampin, and six other drugs. These observations are important for the therapy of multidrug-resistant tuberculosis.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference18 articles.
1. In Vitro and In Vivo Activities of Gatifloxacin against
Mycobacterium tuberculosis
2. Coletsos, P. J. 1970. Experimental comparative study of the concentration of cycloserine in the serum and viscera in conventional laboratory animals and in the monkey. Scand. J. Respir. Dis. Suppl.71:40-50.
3. Activities of Several Novel Oxazolidinones against
Mycobacterium tuberculosis
in a Murine Model
4. Fattorini, L., E. Iona, M. L. Ricci, O. F. Thoresen, G. Orrù, M. R. Oggioni, E. Tortoli, C. Piersimoni, P. Chiaradonna, M. Tronci, G. Pozzi, and G. Orefici. 1999. Activity of 16 antimicrobial agents against drug-resistant strains of Mycobacterium tuberculosis. Microb. Drug Resist.5:265-270.
5. Heifets L. B. 1991. Antituberculous drugs: activity in vitro p. 13-57. In L. B. Heifets (ed.) Drug susceptibilities in the chemotherapy of mycobacterial infections. CRC Press Inc. Boca Raton Fla.
Cited by
43 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献